These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34213342)

  • 1. Addressing a Trapped High-Energy Water: Design and Synthesis of Highly Potent Pyrimidoindole-Based Glycogen Synthase Kinase-3β Inhibitors.
    Andreev S; Pantsar T; Tesch R; Kahlke N; El-Gokha A; Ansideri F; Grätz L; Romasco J; Sita G; Geibel C; Lämmerhofer M; Tarozzi A; Knapp S; Laufer SA; Koch P
    J Med Chem; 2022 Jan; 65(2):1283-1301. PubMed ID: 34213342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis and Biological Evaluation of 7-Chloro-9
    Andreev S; Pantsar T; Ansideri F; Kudolo M; Forster M; Schollmeyer D; Laufer SA; Koch P
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31242571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and Evaluation of Enantiopure 9
    Andreev S; Pantsar T; El-Gokha A; Ansideri F; Kudolo M; Anton DB; Sita G; Romasco J; Geibel C; Lämmerhofer M; Goettert MI; Tarozzi A; Laufer SA; Koch P
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of pyrimidin-4-one-1,2,3-triazole conjugates as glycogen synthase kinase-3β inhibitors with anti-depressant activity.
    Khan I; Tantray MA; Hamid H; Alam MS; Kalam A; Hussain F; Dhulap A
    Bioorg Chem; 2016 Oct; 68():41-55. PubMed ID: 27454617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel β-carboline derivatives as selective AChE inhibitors with GSK-3β inhibitory property for the treatment of Alzheimer's disease.
    Liu W; Liu X; Liu W; Gao Y; Wu L; Huang Y; Chen H; Li D; Zhou L; Wang N; Xu Z; Jiang X; Zhao Q
    Eur J Med Chem; 2022 Feb; 229():114095. PubMed ID: 34995924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis and in Vitro Tumor Cytotoxicity Evaluation of 3,5-Diamino-N-substituted Benzamide Derivatives as Novel GSK-3β Small Molecule Inhibitors.
    Zhou Y; Zhang L; Fu X; Jiang Z; Tong R; Shi J; Li J; Zhong L
    Chem Biodivers; 2019 Sep; 16(9):e1900304. PubMed ID: 31338947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease.
    Liu W; Liu X; Tian L; Gao Y; Liu W; Chen H; Jiang X; Xu Z; Ding H; Zhao Q
    Eur J Med Chem; 2021 Oct; 222():113554. PubMed ID: 34098466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design of 4-amino-5,6-diaryl-furo[2,3-d]pyrimidines as potent glycogen synthase kinase-3 inhibitors.
    Miyazaki Y; Maeda Y; Sato H; Nakano M; Mellor GW
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1967-71. PubMed ID: 18280153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of new GSK-3β inhibitors through structure-based virtual screening.
    Dou X; Jiang L; Wang Y; Jin H; Liu Z; Zhang L
    Bioorg Med Chem Lett; 2018 Jan; 28(2):160-166. PubMed ID: 29208522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of Coumarin Derivatives as Versatile Scaffolds for GSK-3β Enzyme Inhibition.
    Francisco CS; Javarini CL; de S Barcelos I; Morais PAB; de Paula H; de S Borges W; Neto ÁC; Lacerda V
    Curr Top Med Chem; 2020; 20(2):153-160. PubMed ID: 31648640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capturing the Effects of Single Atom Substitutions on the Inhibition Efficiency of Glycogen Synthase Kinase-3β Inhibitors via Markov State Modeling and Experiments.
    Mehrani R; Mondal J; Ghazanfari D; Goetz DJ; McCall KD; Bergmeier SC; Sharma S
    J Chem Theory Comput; 2024 Jul; 20(14):6278-6286. PubMed ID: 38975986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition.
    Redenti S; Marcovich I; De Vita T; Pérez C; De Zorzi R; Demitri N; Perez DI; Bottegoni G; Bisignano P; Bissaro M; Moro S; Martinez A; Storici P; Spalluto G; Cavalli A; Federico S
    ChemMedChem; 2019 Feb; 14(3):310-314. PubMed ID: 30548443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of 5-benzylidene-2-iminothiazolidin-4-ones as selective GSK-3β inhibitors.
    Arfeen M; Bhagat S; Patel R; Prasad S; Roy I; Chakraborti AK; Bharatam PV
    Eur J Med Chem; 2016 Oct; 121():727-736. PubMed ID: 27423119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First dual AK/GSK-3β inhibitors endowed with antioxidant properties as multifunctional, potential neuroprotective agents.
    Brogi S; Ramunno A; Savi L; Chemi G; Alfano G; Pecorelli A; Pambianchi E; Galatello P; Compagnoni G; Focher F; Biamonti G; Valacchi G; Butini S; Gemma S; Campiani G; Brindisi M
    Eur J Med Chem; 2017 Sep; 138():438-457. PubMed ID: 28689095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of (aza)indolyl maleimide-based covalent inhibitors of glycogen synthase kinase 3β.
    Yang Z; Liu H; Pan B; He F; Pan Z
    Org Biomol Chem; 2018 Jun; 16(22):4127-4140. PubMed ID: 29781013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Selective, Substrate-Competitive, and Passive Membrane Permeable Glycogen Synthase Kinase-3β Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling of New C-Glycosylflavones.
    Liang Z; Li QX
    ACS Chem Neurosci; 2018 May; 9(5):1166-1183. PubMed ID: 29381861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discovery of novel benzothiazinones as highly selective non-ATP competitive glycogen synthase kinase 3β inhibitors for the treatment of ovarian cancer.
    Gao Y; Ye DY; Zhou WC; Chu Y
    Eur J Med Chem; 2017 Jul; 135():370-381. PubMed ID: 28460311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Based Design of Potent Selective Nanomolar Type-II Inhibitors of Glycogen Synthase Kinase-3β.
    Davies MP; Benitez R; Perez C; Jakupovic S; Welsby P; Rzepecka K; Alder J; Davidson C; Martinez A; Hayes JM
    J Med Chem; 2021 Feb; 64(3):1497-1509. PubMed ID: 33499592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 9-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma.
    Ugolkov AV; Bondarenko GI; Dubrovskyi O; Berbegall AP; Navarro S; Noguera R; O'Halloran TV; Hendrix MJ; Giles FJ; Mazar AP
    Anticancer Drugs; 2018 Sep; 29(8):717-724. PubMed ID: 29846250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.